Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
24,914,233
-
Share change
-
+1,144,729
-
Total reported value
-
$1,213,678,817
-
Put/Call ratio
-
203%
-
Price per share
-
$48.76
-
Number of holders
-
122
-
Value change
-
+$61,212,311
-
Number of buys
-
70
-
Number of sells
-
39
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q4 2015
As of 31 Dec 2015,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,914,233 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, OAK RIDGE INVESTMENTS LLC, Polaris Venture Management Co IV LLC, VANGUARD GROUP INC, Sectoral Asset Management Inc, BlackRock Fund Advisors, JPMORGAN CHASE & CO, MILLENNIUM MANAGEMENT LLC, and GRANAHAN INVESTMENT MANAGEMENT INC/MA.
This page lists
122
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.